| Serial Number | 79344182 |
| Word Mark | BIOTHEUS |
| Filing Date | Thursday, April 14, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 7, 2023 |
| Registration Number | 7209518 |
| Registration Date | Tuesday, November 7, 2023 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 22, 2023 |
| NOT AVAILABLE | THE CHINESE CHARACTERS WHICH TRANSLITERATE TO "SHENG WU JI SHU" |
| Goods and Services | Medicines used for treating cancers; biological preparations used for treating cancer; anti-cancer pharmaceutical preparations; medicines for human purposes for the treatment of cancer, immune function affection, nervous system diseases, respiratory system diseases, hematological system diseases, circulatory system diseases, hypertensive diseases, diabetic diseases, digestive system diseases, bone and joint diseases, endocrine and metabolic system diseases, ankylosing spondylitis disease, psoriasis, lupus erythematosus disease, rheumatoid arthritis diseases, immunomodulatory diseases, urinary system diseases, skin system diseases, reproductive system diseases; pharmaceutical preparations for the treatment of cancer, immune function affection, nervous system diseases, respiratory system diseases, hematological system diseases, circulatory system diseases, hypertensive diseases, diabetic diseases, digestive system diseases, bone and joint diseases, endocrine and metabolic system diseases, ankylosing spondylitis disease, psoriasis, lupus erythematosus disease, rheumatoid arthritis diseases, immunomodulatory diseases, urinary system diseases, skin system diseases, reproductive system diseases; chemico-pharmaceutical preparations for the treatment of cancer, immune function affection, nervous system diseases, respiratory system diseases, hematological system diseases, circulatory system diseases, hypertensive diseases, diabetic diseases, digestive system diseases, bone and joint diseases, endocrine and metabolic system diseases, ankylosing spondylitis disease, psoriasis, lupus erythematosus disease, rheumatoid arthritis diseases, immunomodulatory diseases, urinary system diseases, skin system diseases, reproductive system diseases; medicines for medical purposes for the treatment of cancer, immune function affection, nervous system diseases, respiratory system diseases, hematological system diseases, circulatory system diseases, hypertensive diseases, diabetic diseases, digestive system diseases, bone and joint diseases, endocrine and metabolic system diseases, ankylosing spondylitis disease, psoriasis, lupus erythematosus disease, rheumatoid arthritis diseases, immunomodulatory diseases, urinary system diseases, skin system diseases, reproductive system diseases; chemical preparations for pharmaceutical purposes for the treatment of cancer, immune function affection, nervous system diseases, respiratory system diseases, hematological system diseases, circulatory system diseases, hypertensive diseases, diabetic diseases, digestive system diseases, bone and joint diseases, endocrine and metabolic system diseases, ankylosing spondylitis disease, psoriasis, lupus erythematosus disease, rheumatoid arthritis diseases, immunomodulatory diseases, urinary system diseases, skin system diseases, reproductive system diseases; biological preparations for medical purposes for the treatment of cancer, immune function affection, nervous system diseases, respiratory system diseases, hematological system diseases, circulatory system diseases, hypertensive diseases, diabetic diseases, digestive system diseases, bone and joint diseases, endocrine and metabolic system diseases, ankylosing spondylitis disease, psoriasis, lupus erythematosus disease, rheumatoid arthritis diseases, immunomodulatory diseases, urinary system diseases, skin system diseases, reproductive system diseases; biochemicial medicines for the treatment of cancer, immune function affection, nervous system diseases, respiratory system diseases, hematological system diseases, circulatory system diseases, hypertensive diseases, diabetic diseases, digestive system diseases, bone and joint diseases, endocrine and metabolic system diseases, ankylosing spondylitis disease, psoriasis, lupus erythematosus disease, rheumatoid arthritis diseases, immunomodulatory diseases, urinary system diseases, skin system diseases, reproductive system diseases; medicines in the form of injections for the treatment of cancer, immune function affection, nervous system diseases, respiratory system diseases, hematological system diseases, circulatory system diseases, hypertensive diseases, diabetic diseases, digestive system diseases, bone and joint diseases, endocrine and metabolic system diseases, ankylosing spondylitis disease, psoriasis, lupus erythematosus disease, rheumatoid arthritis diseases, immunomodulatory diseases, urinary system diseases, skin system diseases, reproductive system diseases |
| Goods and Services | Scientific research in the field of medication evaluation; quality control evaluation for others; scientific research in the nature of conducting clinical trials for others; scientific research in the field of antibody; services of medical laboratory |
| Description of Mark | The mark consists of the wording "BIOTHEUS" in stylized font above seven Chinese characters positioned horizontally; to the right of the literal element is the stylized depiction of six curving lines of varying sizes surrounding a single shaded dot. |
| NOT AVAILABLE | The transliteration of the non-Latin characters in the mark is "PU MI SI SHENG WU JI SHU" wherein the word "PU" means "GENERAL," the word "MI" means "METER," the word "SI" means "THIS," and the wording "SHENG WU JI SHU" means "BIOTECHNOLOGY" in English, and the combination of Chinese characters as a whole has no meaning. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 8, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 8, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BioNTech (Zhuhai) Pharmaceuticals R&D Co., Ltd. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 98 - Unknown |
| Address | CN |
| Party Name | Biotheus Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Zhuhai, Guangdong 519080 CN |
| Party Name | Biotheus Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Zhuhai, Guangdong 519080 CN |
| Party Name | Biotheus Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Zhuhai, Guangdong 519080 CN |
| Event Date | Event Description |
| Thursday, July 7, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, July 8, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 12, 2022 | APPLICATION FILING RECEIPT MAILED |
| Saturday, September 10, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, February 1, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, February 7, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 8, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, March 30, 2023 | REFUSAL PROCESSED BY MPU |
| Thursday, March 30, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, April 19, 2023 | REFUSAL PROCESSED BY IB |
| Thursday, July 13, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, July 13, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 13, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, July 14, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 2, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, August 2, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, August 2, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Monday, August 21, 2023 | NOTIFICATION PROCESSED BY IB |
| Tuesday, August 22, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 22, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 7, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, November 7, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Wednesday, February 7, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Thursday, February 8, 2024 | FINAL DISPOSITION PROCESSED |
| Thursday, February 8, 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, March 4, 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, June 25, 2026 | CHANGE OF NAME/ADDRESS REC'D FROM IB |